Brainlab's ExacTrac Patient Positioning System Achieves Major Sales Milestone

January 12, 2012 — Today Brainlab announced the 500th sale of its ExacTrac patient positioning system for frameless radiosurgery. The scale of uptake highlights physicians continued focus on adopting clinically proven systems for high-precision cancer treatments and their ongoing investment in ensuring access to advanced radiation therapy for patients.

The ExacTrac system, first developed almost a decade ago, has proven consistent and reliable in supporting accurate frameless radiosurgery for patients with tumors of the brain, spine and beyond. The system has since been internationally recognized as offering high accuracy, flexibility and increased patient comfort during treatment.

ExacTrac works by combining with advanced radiosurgery treatment systems to allow physicians to treat cancers using a frameless radiosurgery technique. This offers a valuable alternative to the historical practice that requires immobilization with an invasive head ring affixed to the skull. The advanced image guidance and computer-driven optimization of ExacTrac enables physicians to control every step of the treatment pathway, improving workflow and flexibility of treatment planning.

By offering precision to a sub-millimeter level, ExacTrac  provides accuracy during the entire procedure and helps reduce errors within the process, therefore maximizing overall treatment accuracy. By offering the option of non-invasive frameless radiosurgery, physicians are also able to offer patients a better treatment experience, increasing comfort and reducing anxiety during the procedure.

The adoption rate of ExacTrac frameless radiosurgery has increased significantly over the last few years. A growing number of physicians worldwide fully rely on the frameless technique for intra-cranial radiosurgery treatments and have eliminated the use of the invasive head ring completely.

For more information: www.brainlab.com

Related Content

News | Quality Assurance (QA)

October 11, 2021 — To maintain safety in radiation therapy (RT), every machine performance and patient delivery ...

Time October 11, 2021
arrow
News | Radiation Therapy

October 7, 2021 — NANOBIOTIX, a late-stage clinical biotechnology company pioneering physics-based approaches to expand ...

Time October 07, 2021
arrow
Feature | Radiation Therapy | By Dave Fornell

To maintain safety in radiation therapy (RT), every machine performance and patient delivery measurement must be as ...

Time October 05, 2021
arrow
Feature | Radiation Therapy

September 28, 2021 — New research from Washington University School of Medicine in St. Louis suggests that radiation ...

Time September 28, 2021
arrow
News | Radiation Oncology

September 28, 2021 — The global radiotherapy devices market is expected to grow from $5.44 billion in 2020 to $5.848 ...

Time September 28, 2021
arrow
News | Prostate Cancer

September 24, 2021 — Scientists have identified two subtypes of metastatic prostate cancer that respond differently to ...

Time September 24, 2021
arrow
News | Radiation Therapy

September 24, 2021 — The "Global Surface Guided Radiation Therapy (SGRT) Devices Market, By Device Type (Portable v/s ...

Time September 24, 2021
arrow
News | Lung Imaging

September 23, 2021 — The National Cancer Institute announced that Virginia Commonwealth University Massey Cancer Center ...

Time September 23, 2021
arrow
News | Radiation Oncology

September 21, 2021 — The development of new research guidelines for interventional oncology that standardize treatment ...

Time September 21, 2021
arrow
News | Radiation Oncology

September 20, 2021 — The rapid pace of developments in the oncology field, mainly brought by cancer immunotherapy, means ...

Time September 20, 2021
arrow
Subscribe Now